Form 4: MaxCyte CFO Douglas Swirsky Reports Sale of Shares to Cover Tax Obligations

Douglas Swirsky, CFO of MaxCyte, Inc., reported the sale of 6,939 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 18, 2025, Douglas J. Swirsky, the Chief Financial Officer of MaxCyte, Inc. (MXCT), sold 6,939 shares of common stock.
• The sale was executed to cover tax withholding obligations arising from the vesting of previously granted restricted stock units (RSUs).
• The shares were sold at a weighted average price of $3.1793 per share, with individual transactions ranging from $3.14 to $3.215.
• Following the transaction, Swirsky directly owns 111,811 shares of MaxCyte common stock.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (sale of shares for tax obligations) by a company executive, which is neither particularly positive nor negative. It's a neutral event in the context of investment analysis.

Industry Context

Sales of shares by company executives to cover tax obligations upon vesting of restricted stock units are a common practice and generally don't indicate a negative outlook on the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

MaxCyte, MXCT, Douglas Swirsky, CFO, Form 4, Share Sale, Restricted Stock Units, Tax Withholding, Beneficial Ownership